Human cytomegalovirus infection of immature dendritic cells and macrophages

Intervirology

Volumn 42, Issue 5-6, 1999, Pages 365-372

  Jahn, Gerhard ^a,b   Stenglein, Stephan ^a   Riegler, Susanne ^a   Einsele, Hermann ^a   Sinzger, Christian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Antigen presenting cells; Human cytomegalovirus; Immature dendritic cells; Immunosuppression; Macrophages; Pathogenesis

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL TYPE; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; CYTOPATHOGENIC EFFECT; DENDRITIC CELL; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

HUMAN HERPESVIRUS 5;

EID: 0343114299     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053973     Document Type: Conference Paper

References (55)

1. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392: 245-252.
2. Becker Y: Chapter 22 Postscript: What is the role of dendritic cells in the pathogenesis of human cytomegalovirus in immunocompetent and immunocompromised hosts?; in Molecular Aspects of Human Cytomegalovirus Diseases. Berlin, Springer, 1993.
3. Bender A, Albert M, Reddy A, Feldman M, Sauter B, Kaplan G, Hellman W, Bhardwaj N: The distinctive features of influenza virus infection of dendritic cells. Immunobiology 1997/1998; 198:552-567.
4. Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM: Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest 1994;94:797-807.
5. Brossart P, Bevan MJ: Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines. Blood 1997;90:1594-1599.
6. Brossart P, Goldrath AW, Butz EA, Martin S, Bevan MJ: Virus-mediated delivery of antigeneic epitopes into dendritic cells as a means to induce CTL. J Immunol 1997;158:3270-3276.
7. Daar AS, Fuggle SV, Hart DNJ, Dalchau R, Abdulaziz Z, Fabre JW, Ting A, Morris PJ: Demonstration and phenotypic characterization of HLA-DR positive interstitial dendritic cells widely distributed in human connective tissues. Transplant Proc 1983;1:311.
8. Einsele H, Ehninger G, Hebart H, Schuler U, Mackes P, Hertter M, Klingebiel T, Löffler J, Wagner S, Müller CA: PCR-monitoring after BMT to reduce the incidence of CMV disease and the duration and side effects of antiviral therapy. Blood 1995;86:2815-2820.
9. Einsele H, Fleckenstein B, Jahn G, Koszinowski U, v Laer D, Mertens T, Mach M, Hebart H, Bock T, Müller C, Plachter B, Reddehase MJ, Schmidt CA, Stamminger T: Forschungsverbund: Komplikationen der Organtransplantation durch Herpesviren: Empfehlung zur Diagnostik und Therapie der Zytomegalievirus-Infektion nach Stammzelltransplantation. Dtsche Med Wochenschr 1999;124:501-506.
10. Einsele H, Hebart H, Kauffmann C, Sinzger C, Jahn G, Bader P, Klingebiel T, Dietz K, Löffer J, Bokemeyer C, Müller CA, Kanz L: Risk factors for treatment failures in patients receiving PCR-based preemptive antiviral therapy. Bone Marrow Transplant, in press.
11. Fish KN, Britt W, Nelson JA: A novel mechanism for persistence of human cytomegalovirus in macrophages. J Virol 1996;70:1855-1862.
12. Fish KN, Depto AS, Moses AV, Britt W, Nelson JA: Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J Virol 1995;69:3737-3743.
13. Grouard G, Clark E: Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis. Curr Opin Immunol 1997;9:563-567.
14. Hahn G, Jores R, Mocarski ES: Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Microbiology 1998;95: 3937-3942.
15. Halwachs-Baumann G, Wilders-Truschnig M, Desoye G, Hahn T, Kiesel L, Klingel K, Rieger P, Jahn G, Sinzger C: Human trophoblast cells are permissive to the complete replicative cycle of human cytomegalovirus. J Virol 1998;72: 7598-7602.
16. Hart DNJ: Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 1997;90:3245-3287.
17. Hart DNJ, Calder VL: Human dendritic cells: Function and cytokine production. Immunopharmacology of macrophages and other antigen-presenting cells; in Bruijnzel-Koomen CFAM, Hoefsmit ECM (eds): Handbook of Immunopharmacology. London, Academic Press, 1994, p 63.
18. Hart DNJ, Fabre JW: Demonstration and characterization of la-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues but not brain. J Exp Med 1981; 153:347.
19. Hladik F, Lentz G, Akridge RE, Peterson G, Kelley H, McElroy A, McElrath MJ: Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract. J Virol 1999;73/7:5833-5842.
20. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA: Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991;65:6581-6588.
21. Inaba K, Witmer-Pack MD, Steinman RM: Clustering of dendritic cells, helper T lymphocytes and histocompatible B cells, during primary antibody responses in vitro. J Exp Med 1984; 160:858.
22. Jahn G, Harthus H-P, Bröker M, Borisch B, Platzer B, Plachter B: Generation and application of monoclonal antibody raised against a recombinant cytomegalovirus-specific polypeptide. Klin Wochenschr 1990;68:1003-1007.
23. Jahn G, Scholl B-C, Traupe B, Fleckenstein B: The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. J Gen Virol 1987;68: 1327-1337.
24. Klagge IM, Schneider-Schaulis S: Virus interactions with dendritic cells. J Gen Virol 1999;80: 823-833.
25. Knight SC, Elsley W, Wang H: Mechanisms of loss of functional dendritic cells in HIV-1 infection. J Leucoc Biol 1997;62:78-81.
26. Knight SC, Macatonia SE, Patterson S: Infection of dendritic cells with HIV-1: Virus load regulates stimulation and suppression of T cell activity. Res Virol 1993;144:75-80.
27. Knight SC, Patterson S: Bone marrow-derived dendritic cells, infection with human deficiency virus, and immunopathology. Ann Rev Immunol 1997;15:593-615.
28. Krause H, Hebart H, Jahn G, Müller CA, Einsele H: Screening for CMV-specific T-cell proliferation to identity patients at risk to develop late onset CMV disease. Bone Marrow Transplant 1997;19:1111-1116.
29. Langerhans P: Über die Nerven der menschlichen Haut. Virchows Arch 1868;44:325-327.
30. Lathey JL, Spector SA: Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J Virol 1991;65:6371-6375.
31. Mazeron MC, Jahn G, Plachter B: Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene. J Gen Virol 1992;73:2699-2703.
32. Mendelson M, Monard S, Sissons P, Sinclair J: Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 1996;77:3099-3102.
33. McKenzie JL, Beard MEJ, Hart DNJ: Depletion of donor kidney dendritic cells prolongs graft survival. Tran Procsplant 1984;16:948.
34. Minton EJ, Tysoe C, Sinclair JH, Sissons JGP: Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol 1994;68:4017-4021.
35. Patterson S, English NR, Longhurst H, Balfe P, Helbert M, Pinching AJ, Knight SC: Analysis of human immunodeficiency virus type 1 (HIV-1) variants and levels of infection in dendritic and T cells from symptomatic HIV-1 patients. J Gen Virol 1998;79:247-257.
36. Plachter B, Nordin M, Zweygberg Wirgart B, Mach M, Stein H, Grillner L, Hahn G: The DNA binding protein p52 of human cytomegalovirus reacts with monoclonal antibody CCH2 and associates with the nuclear membrane at late times after infection. Virus Res 1992a;24:265-276.
37. Plachter B, Sinzger C, Jahn G: Cell types involved in replication and distribution of human cytomegalovirus. Virus Res 1996;46:195-261.
38. Plachter B, Wieczorek L, Scholl B-C, Ziegelmaier R, Jahn G: Detection of cytomegalovirus antibodies by an ELISA using recombinant polypeptides of the large phosphorylated tegument protein pp150. J Clin Microbiol 1992b;30: 201-206
39. Reid CDL: The biology and clinical applications of dendritic cells. Transfus Med 1998;8:77-86.
40. Riegler S, Sinzger C, Jahn G: Efficient productive infection of dendritic cells by endotheliotropic strains of the human cytomegalovirus (abstract 4.003). 24th Int Herpesvirus Workshop. Cambridge, Mass., 1999.
41. Riegler S, Hebart H, Einsele H, Brossart P, Jahn G, Sinzger C: Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J Gen Virol 2000; 81:393-394.
42. Schnorr JJ, Seufert M, Schlender J, Borst J, Johnston ICD, ter Meulen V, Schneider-Schaulies S: Cell cycle arrest rather than apoptosis is associated with measles virus contact-mediated immunosuppression in vitro. J Gen Virol 1997a; 78:3217-3226.
43. Schnorr JJ, Xantahkos S, Keikavoussi P, Kämpgen E, ter Meulen V, Schneider-Schaulies S: Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci USA 1997b;94:5326-5331.
44. Scholl B-C, v. Hintzenstern J, Borisch B, Traupe B, Bröker M. Jahn G: Prokaryotic expression of immunogenic polypeptides of the large phosphoprotein (pp150) of human cytomegalovirus. J Gen Virol 1988;69:1195-1204.
45. Sinzger C, Bissinger AL, Viebahn R, Oettle H, Radke C, Schmidt CA, Jahn G: Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and in vivo. J Infect Dis 1999;180:976-986.
46. Sinzger C, Grefte A, Plachter B, Gouw ASH, The TH, Jahn G: Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 1995;76:741-750.
47. Sinzger C, Jahn G: Human cytomegalovirus cell tropism and pathogenesis. Intervirology 1996, 39:302-319.
48. Sinzger C, Müntefering H, Löning T, Stöss H, Plachter B, Jahn G: Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Arch A Pathol Anat 1993;423:249-256.
49. Sinzger C, Plachter B, Grefte A, The TH, Jahn G: Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis 1996;173: 240-245.
50. Söderberg-Nauclér C, Fish KN, Nelson JA: Growth of human cytomegalovirus in primary macrophages. Methods 1998;16:126-138.
51. Söderberg-Nauclér C, Fish KN. Nelson JA: Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997;91:119-126.
52. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271.
53. Steinman RM, Lustig DS, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. III. Functional properties in vivo. J Exp Med 1974;139:1431.
54. Taylor-Wiedeman J, Sissons JGP, Borysiewicz LK, Sinclair JH: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991;72:2059-2064.
55. Younes M, Podesta A, Helic M, Buckley P: Infection of T but not B lymphocytes by cytomegalovirus in lymph node. Am J Surg Pathol 1991; 15:75-80.